Literature DB >> 9029080

Genetic evidence for the involvement of tau in progressive supranuclear palsy.

C Conrad1, A Andreadis, J Q Trojanowski, D W Dickson, D Kang, X Chen, W Wiederholt, L Hansen, E Masliah, L J Thal, R Katzman, Y Xia, T Saitoh.   

Abstract

A dinucleotide repeat polymorphism in a tau intron was identified and used in a case-control study to analyze the genetic association of tau with several neurodegenerative diseases with tau pathology. Subjects with the homozygous tau AO alleles were excessively represented in the progressive supranuclear palsy (PSP) group, compared with the age-matched healthy control group. Consequently, this allele is more frequently found in PSP than in a group of healthy subjects. This trend was not found in Alzheimer's disease or parkinsonism-dementia complex of Guam, both of which are accompanied by major tau pathology. The result suggests a possible involvement of tau in the pathogenesis of PSP.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029080     DOI: 10.1002/ana.410410222

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  71 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

Review 2.  Progressive supranuclear palsy.

Authors:  H U Rehman
Journal:  Postgrad Med J       Date:  2000-06       Impact factor: 2.401

Review 3.  Progressive supranuclear palsy (Steele-Richardson-Olszewski disease).

Authors:  H R Morris; N W Wood; A J Lees
Journal:  Postgrad Med J       Date:  1999-10       Impact factor: 2.401

4.  Analysis of the exon 1 polymorphism in the Tau gene in transmissible spongiform encephalopathies.

Authors:  Raquel Sánchez-Valle; Pau Pastor; Jordi Yagüe; Teresa Ribalta; Francesc Graus; Eduardo Tolosa; Albert Saiz
Journal:  J Neurol       Date:  2002-07       Impact factor: 4.849

5.  Resolving the breakpoints of the 17q21.31 microdeletion syndrome with next-generation sequencing.

Authors:  Andy Itsara; Lisenka E L M Vissers; Karyn Meltz Steinberg; Kevin J Meyer; Michael C Zody; David A Koolen; Joep de Ligt; Edwin Cuppen; Carl Baker; Choli Lee; Tina A Graves; Richard K Wilson; Robert B Jenkins; Joris A Veltman; Evan E Eichler
Journal:  Am J Hum Genet       Date:  2012-04-06       Impact factor: 11.025

Review 6.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

Review 7.  Frontotemporal lobar degeneration: current knowledge and future challenges.

Authors:  Chiara Cerami; Elio Scarpini; Stefano F Cappa; Daniela Galimberti
Journal:  J Neurol       Date:  2012-04-25       Impact factor: 4.849

Review 8.  Knock-out and transgenic mouse models of tauopathies.

Authors:  Franziska Denk; Richard Wade-Martins
Journal:  Neurobiol Aging       Date:  2007-06-22       Impact factor: 4.673

9.  Microtubule-associated protein tau genetic variations are uncommon cause of frontotemporal dementia in south India.

Authors:  P M Aswathy; P S Jairani; Joe Verghese; Srinivas Gopala; P S Mathuranath
Journal:  Neurobiol Aging       Date:  2013-09-13       Impact factor: 4.673

10.  Linkage disequilibrium and association of MAPT H1 in Parkinson disease.

Authors:  Lisa Skipper; Kristen Wilkes; Mathias Toft; Matthew Baker; Sarah Lincoln; Mary Hulihan; Owen A Ross; Mike Hutton; Jan Aasly; Matthew Farrer
Journal:  Am J Hum Genet       Date:  2004-08-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.